These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 24592948)

  • 1. Cancer therapy using oligonucleotide-based STAT3 inhibitors: will they deliver?
    Kortylewski M; Nechaev S
    Ther Deliv; 2014 Mar; 5(3):239-42. PubMed ID: 24592948
    [No Abstract]   [Full Text] [Related]  

  • 2. Atelocollagen-mediated siRNA delivery: future promise for therapeutic application.
    Fujimoto I; Takei Y
    Ther Deliv; 2014 Apr; 5(4):369-71. PubMed ID: 24856162
    [No Abstract]   [Full Text] [Related]  

  • 3. Current Challenges in Delivery and Cytosolic Translocation of Therapeutic RNAs.
    Johannes L; Lucchino M
    Nucleic Acid Ther; 2018 Jun; 28(3):178-193. PubMed ID: 29883296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA interference for the treatment of cancer.
    Putral LN; Gu W; McMillan NA
    Drug News Perspect; 2006; 19(6):317-24. PubMed ID: 16971967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Molecular mechanisms involved in regulation of proliferation and apoptosis by STAT3 antisense oligonucleotide and chemotherapy in laryngeal cancer cells].
    Wang JG; Li XM; Chen YH; Lu XY
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Mar; 42(3):222-6. PubMed ID: 17633284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional graphene oxide as a plasmid-based Stat3 siRNA carrier inhibits mouse malignant melanoma growth in vivo.
    Yin D; Li Y; Lin H; Guo B; Du Y; Li X; Jia H; Zhao X; Tang J; Zhang L
    Nanotechnology; 2013 Mar; 24(10):105102. PubMed ID: 23425941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy for cancer.
    Kipps TJ
    J Hematother; 1993; 2(3):367-72. PubMed ID: 7921998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of STAT3 antisense oligonucleotide on proliferation and apoptosis of non-small cell lung cancer cell line A549].
    Zhu BR; Cai JM; Tang GS; Li BL; Gao F; Cui JG; Liu HC
    Ai Zheng; 2007 Aug; 26(8):820-7. PubMed ID: 17697540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combinatorial RNAi and its application in cancer gene therapy].
    Fei LN; Wang QZ; Xu RA
    Yao Xue Xue Bao; 2012 May; 47(5):573-9. PubMed ID: 22811998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Advances in research on RNA interference-related drugs for cancer treatment].
    Ren HW; Yang BX
    Zhonghua Zhong Liu Za Zhi; 2012 Nov; 34(11):801-4. PubMed ID: 23291125
    [No Abstract]   [Full Text] [Related]  

  • 11. STAT3-targeting RNA interference inhibits pancreatic cancer angiogenesis in vitro and in vivo.
    Huang C; Jiang T; Zhu L; Liu J; Cao J; Huang KJ; Qiu ZJ
    Int J Oncol; 2011 Jun; 38(6):1637-44. PubMed ID: 21479358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Encapsulation of nucleic acids and opportunities for cancer treatment.
    Brannon-Peppas L; Ghosn B; Roy K; Cornetta K
    Pharm Res; 2007 Apr; 24(4):618-27. PubMed ID: 17372693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting transcription factors: promising new strategies for cancer therapy.
    Yeh JE; Toniolo PA; Frank DA
    Curr Opin Oncol; 2013 Nov; 25(6):652-8. PubMed ID: 24048019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The inhibitory effect of RNA interference on STAT3 expression in liver cancer cell line SMMC7721].
    Liao WJ; Mei MH; Qin LL; Chen Q; Yuan SG; Liu J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jun; 27(6):615-7. PubMed ID: 21651859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA activation: promise as a new weapon against cancer.
    Zheng L; Wang L; Gan J; Zhang H
    Cancer Lett; 2014 Dec; 355(1):18-24. PubMed ID: 25261049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiapoptotic Bcl-2 protein as a potential target for cancer therapy: A mini review.
    Jagani H; Kasinathan N; Meka SR; Josyula VR
    Artif Cells Nanomed Biotechnol; 2016 Aug; 44(5):1212-21. PubMed ID: 25801037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery of interferons and siRNA targeting STAT3 using lentiviral vectors suppresses the growth of murine melanoma.
    Wang X; Liu P; Liu H; Yang W; Liu Z; Zhuo Z; Gao Y
    Cancer Gene Ther; 2012 Dec; 19(12):822-7. PubMed ID: 23018621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stat3-driven cancer-related inflammation as a key therapeutic target for cancer immunotherapy.
    Kato T
    Immunotherapy; 2011 May; 3(5):587-90. PubMed ID: 21554086
    [No Abstract]   [Full Text] [Related]  

  • 19. Silencing of the transcription factor STAT3 sensitizes lung cancer cells to DNA damaging drugs, but not to TNFα- and NK cytotoxicity.
    Kulesza DW; Carré T; Chouaib S; Kaminska B
    Exp Cell Res; 2013 Feb; 319(4):506-16. PubMed ID: 23149124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA interference: a potent tool for gene-specific therapeutics.
    Ichim TE; Li M; Qian H; Popov IA; Rycerz K; Zheng X; White D; Zhong R; Min WP
    Am J Transplant; 2004 Aug; 4(8):1227-36. PubMed ID: 15268723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.